Preliminary Results of Paclitaxel, Cisplatin and Concurrent High-Dose Radiation Therapy for Locally Advanced Non-Small-Cell Lung Cancer
Cancer Research and Treatment 2002³â 34±Ç 5È£ p.345 ~ p.351
ÀÌ»ó¿í(Lee Sang-Wook) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
ÃÖÀº°æ(Choi Eun-Kyung) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
¿À¼®Áß(Oh Suk-Joong) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
(Suh Cheol-Won) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
±è»óÀ§(Kim Sang-We) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
ÀÌÁ¤½Å(Lee Jung-Shin) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
±èµ¿¼ø(Kim Dong-Soon) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
±è¿øµ¿(Kim Won-Dong) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
±è¿ì¼º(Kim Woo-Seong) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
ÀÌ»óµµ(Lee Sang-Do) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
±èÁ¾ÈÆ(Kim Jong-Hoon) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
¾È½Âµµ(Ahn Seung-Do) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
±è°æÁÖ(Kim Kyoung-Ju) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
³ë¿µÁÖ(Noh Young-Ju) - University of Ulsan College of Medicine Asan Medical Center Department of Radiation Oncology
Abstract
Å°¿öµå
Non-small cell lung cancer, Concurrent chemoradiation, Conformal radiotherapy,
KMID :
0939920020340050345
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
This combined modality has activity with manageable toxicity and 23 months in mean survival time